The Board of Directors at Dewpoint Therapeutics provides strategic guidance and oversight for the company, ensuring that it adheres to its mission of applying biomolecular condensates to drug discovery. Comprised of experienced professionals, including founders, the Board sets long-term goals, monitors performance, and supports executive leadership in making critical business decisions to advance research and development in conditions such as cancer, neurodegeneration, and metabolic disease.
View all